HMO Exclusive Call with Nurse Rely Alon

Thursday, May 3 2018

Dear , Friends,

Please join us for an exclusive conference call with
Dr. Rely Alon, Director, Division of Nursing & Health Professions
Wednesday May 9, 2018 from 10:00 - 11:00 am EDT

For this call — during National Nurses Week — Dr. Alon will discuss her goals for HMO nursing, exciting research developments at the Hadassah Medical Organization, and the interplay between her new professional role and personal commitment to women's rights, women's health, and health education.

Previously, Dr. Alon directed the Henrietta Szold Hadassah-Hebrew University Nursing Extension at Assaf HaRofeh Hospital in Beer Yaakov and headed the Women's Health Center of the Maccabi Sick Fund. One of Israel's few nurse practitioners and a qualified midwife, Dr. Alon has a PhD in gender studies from Bar-Ilan University and a BA in nursing from Tel Aviv University. She was born in Israel to Holocaust survivor parents.

For 100 years, Hadassah nurses have led the way in Israel. Help us mark the 100th anniversary of the Henrietta Szold Hadassah-Hebrew University School of Nursing.

Donate Today

After registering you will receive a confirmation email containing information about joining the meeting.

IMPORTANT: Please note that Dr. Alon cannot offer personal advice on an individual health matter. Questions should be about her work at Hadassah's hospitals or other general questions about nurses in Israel.


Ellen Hershkin (signature)

Ellen Hershkin
National President

There will be nothing displayed during the call. This is ONLY an audio conference. Due to persistent audio issues, we will be using an Operator Assisted Conference Call number only. You will no longer have the option to use your computer audio (mic and speakers or headset).

Land lines are recommended since mobile connections are known to be less stable. Do NOT use a speakerphone because they can cause echoes, feedback and garbled audio.


No comments yet.
First Name
Enter this word:

Related Stories


Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.


Monday, May 7 2018

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.


Tuesday, Apr 17 2018

Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Many diseases involve the malfunctioning or dying of cells within the body.


Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?


Donation Questions


(800) 928-0685

Membership Questions


(800) 664-5646

Missions Department


(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005


More ›

Show More